Healthcare
Medikabazaar looks to raise $50mn as it charts a growth-led turnaround
Medikabazaar plans to raise ₹450 crore from existing and new investors as it looks to expand after a whistleblower-led governance scandal a little more than two years ago. The company claims it has turned Ebitda positive and is targeting ₹3,000 crore revenue by FY27.
3 min read06:01 AM ISTAI must be safe, inclusive and sovereign for Indias future: AI4Bharat
AI must be safe, inclusive and sovereign for India's future: AI4Bharat
2 min read18 Feb 2026India focused on practical applications of AI to solve population-scale challenges: Vaishnaw
India focused on practical applications of AI to solve population-scale challenges: Vaishnaw
1 min read18 Feb 2026Regulation please: AI doing its own medical research entails the risk of putting human lives in danger
AI-controlled laboratories that can run their own experiments and invent new cures could revolutionize medicine. Yet, such autonomy mustn’t go unregulated. Rogue agents can easily come up with deadly stuff that we may—or may not—live to regret.
4 min read17 Feb 2026India cracks down on professional blood donor rackets with tougher new rules
The new rules to set up blood centres restrict eligibility to registered voluntary and charitable organizations, barring family societies and trusts, and mandate social accountability evaluation. Professional donors who donate blood for money increase the risk of spreading infections.
4 min read16 Feb 2026W Health Ventures to take bigger, bolder bets in healthcare: Pankaj Jethwani
The firm on Thursday announced the initial close of Fund II at ₹550 crore, aiming to raise ₹630 crore. The fund is about 87% subscribed, and the firm hopes to announce the final close shortly.
2 min read12 Feb 2026OneSource Pharma-Hikma get regulatory approval to sell generic Ozempic in Saudi Arabia
The approval from the Saudi Food and Drug Authority allows the company to enter Saudi Arabia, one of the largest markets for Ozempic and other weight management/loss drugs.
1 min read11 Feb 2026How AI allows us to end the practice of treating animals as a resource for scarce substances
AI-led biotech advances indicate that we may no longer need to treat animals as a ‘resource’ to be ‘mined’ for rare and valuable substances. We now have a path away from extractive biofarming. We can devise and use synthetic replacements.
4 min read10 Feb 2026Niche to necessity: Decoding India’s protein revolution
India's protein market is evolving from niche to a mainstream dietary essential, projected to reach $2.08 billion by 2030. Consumers prioritise protein for health, leading to a surge in high-protein products, particularly ready-to-drink beverages, amid increasing health consciousness post-pandemic.
5 min read10 Feb 2026Why doctors can’t agree on how to dagnose Alzheimer’s
Divergent diagnostic criteria is raising concerns that some patients are being misdiagnosed and unnecessarily treated.
5 min read10 Feb 2026